The antiviral spectra of TRIM5α orthologues and human trim family proteins against lentiviral production

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Ohmine, Seiga ^a   Sakuma, Ryuta ^a,c   Sakuma, Toshie ^a   Thatava, Tayaramma ^a   Takeuch, Hiroaki ^b   Ikeda, Yasuhiro ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; TRIPARTITE MOTIF PROTEIN 5; ANTIVIRUS AGENT; CARRIER PROTEIN; TRIM5 PROTEIN, HUMAN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHLOROCEBUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; LENTIVIRINAE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; RHESUS MONKEY; SEQUENCE ALIGNMENT; VIRION; VIRUS ASSEMBLY; VIRUS PARTICLE; ANIMAL; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; HAPLORHINI; METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA FASCICULARIS; MACACA MULATTA; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIVIRAL AGENTS; BINDING SITES; CARRIER PROTEINS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HAPLORHINI; HIV-1; HUMANS; LENTIVIRUS; VIRAL PROTEINS; VIRION;

EID: 79251548903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016121     Document Type: Article

References (51)

1. Bannert N, Kurth R (2004) Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A 101 Suppl 2: 14572-14579.
2. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. (2001) The sequence of the human genome. Science 291: 1304-1351.
3. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD (2004) Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of Trim5alpha. Proc Natl Acad Sci U S A 101: 10774-10779.
4. Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, et al. (2004) Trim5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 101: 11827-11832.
5. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component Trim5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
6. Yap MW, Nisole S, Lynch C, Stoye JP (2004) Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101: 10786-10791.
7. Perez-Caballero D, Hatziioannou T, Yang A, Cowan S, Bieniasz PD (2005) Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J Virol 79: 8969-8978.
8. Song B, Javanbakht H, Perron M, Park DH, Stremlau M, et al. (2005) Retrovirus restriction by Trim5alpha variants from Old World and New World primates. J Virol 79: 3930-3937.
9. Stremlau M, Perron M, Lee M, Li Y, Song B, et al. (2006) Specific recognition and accelerated uncoating of retroviral capsids by the Trim5alpha restriction factor. Proc Natl Acad Sci U S A 103: 5514-5519.
10. Yap MW, Nisole S, Stoye JP (2005) A Single Amino Acid Change in the SPRY Domain of Human Trim5-alpha Leads to HIV-1 Restriction. Current Biology 15: 73-78.
11. Keckesova Z, Ylinen LM, Towers GJ (2004) The human and African green monkey Trim5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101: 10780-10785.
12. Diaz-Griffero F, Kar A, Perron M, Xiang SH, Javanbakht H, et al. (2007) Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the Trim5alpha B-box 2 domain. J Virol 81: 10362-10378.
13. Nakayama EE, Miyoshi H, Nagai Y, Shioda T (2005) A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey Trim5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J Virol 79: 8870-8877.
14. Maillard PV, Ecco G, Ortiz M, Trono D (2010) The specificity of TRIM5{alpha}-mediated restriction is influenced by its coiled-coil domain. J Virol 84: 5970-5801.
15. Sawyer SL, Wu LI, Emerman M, Malik HS (2005) Positive selection of primate Trim5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 102: 2832-2837.
16. Sakuma R, Noser JA, Ohmine S, Ikeda Y (2007) Rhesus monkey Trim5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nat Med 13: 631-635.
17. Sakuma R, Ohmine S, Mael AA, Noser JA, Ikeda Y (2008) Reply to: No effect of endogenous Trim5alpha on HIV-1 production. Nat Med 14: 236-238.
18. Sakuma R, Noser JA, Ohmine S, Ikeda Y (2007) Inhibition of HIV-1 replication by simian restriction factors, Trim5alpha and APOBEC3G. Gene Ther 14: 185-189.
19. Sakuma R, Ohmine S, Ikeda Y (2009) Determinants for the rhesus monkey TRIM5{alpha}-mediated block of the late phase of HIV-1 replication. J Biol Chem.
20. Asaoka K, Ikeda K, Hishinuma T, Horie-Inoue K, Takeda S, et al. (2005) A retrovirus restriction factor Trim5α is transcriptionally regulated by interferons. Biochem and Biophysical Research Communications 338: 1950-1956.
21. Sakuma R, Mael AA, Ikeda Y (2007) Alpha interferon enhances Trim5alphamediated antiviral activities in human and rhesus monkey cells. J Virol 81: 10201-10206.
22. Li X, Gold B, O'HUigin C, Diaz-Griffero F, Song B, et al. (2007) Unique features of Trim5alpha among closely related human TRIM family members. Virology 360: 419-433.
23. Morner A, Bjorndal A, Albert J, Kewalramani VN, Littman DR, et al. (1999) Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 73: 2343-2349.
24. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291.
25. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, et al. (1992) An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 66: 7517-7521.
26. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, et al. (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149-1158.
27. Gao F, Robertson DL, Carruthers CD, Morrison SG, Jian B, et al. (1998) A comprehensive panel of near-full-length clones and reference sequences for nonsubtype B isolates of human immunodeficiency virus type 1. J Virol 72: 5680-5698.
28. Jin MJ, Hui H, Robertson DL, Muller MC, Barre-Sinoussi F, et al. (1994) Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. Embo J 13: 2935-2947.
29. Kim FM, Kolson DL, Balliet JW, Srinivasan A, Collman RG (1995) V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. J Virol 69: 1755-1761.
30. Luciw PA, Shaw KE, Unger RE, Planelles V, Stout MW, et al. (1992) Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res Hum Retroviruses 8: 395-402.
31. Soares MA, Robertson DL, Hui H, Allan JS, Shaw GM, et al. (1997) A fulllength and replication-competent proviral clone of SIVAGM from tantalus monkeys. Virology 228: 394-399.
32. Bour S, Strebel K (1996) The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J Virol 70: 8285-8300.
33. Zhang F, Hatziioannou T, Perez-Caballero D, Derse D, Bieniasz PD (2006) Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 353: 396-409.
34. Chesebro B, Wehrly K, Nishio J, Perryman S (1992) Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 66: 6547-6554.
35. Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ (1995) Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol 69: 4582-4586.
36. Zhang F, Perez-Caballero D, Hatziioannou T, Bieniasz PD (2008) No effect of endogenous Trim5alpha on HIV-1 production. Nat Med 14: 235-236; author reply 236-238.
37. Charneau P, Borman AM, Quillent C, Guetard D, Chamaret S, et al. (1994) Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 205: 247-253.
38. Ikeda Y, Ylinen LM, Kahar-Bador M, Towers GJ (2004) Influence of gag on human immunodeficiency virus type 1 species-specific tropism. J Virol 78: 11816-11822.
39. Braaten D, Ansari H, Luban J (1997) The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J Virol 71: 2107-2113.
40. Tebit DM, Zekeng L, Kaptue L, Gurtler L, Fackler OT, et al. (2004) Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives. Virology 326: 329-339.
41. Jensen FC, Girardi AJ, Gilden RV, Koprowski H (1964) Infection of Human and Simian Tissue Cultures with Rous Sarcoma Virus. Proc Natl Acad Sci U S A 52: 53-59.
42. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. (2001) The tripartite motif family identifies cell compartments. Embo J 20: 2140-2151.
43. Li X, Sodroski J (2008) The Trim5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. J Virol 82: 11495-11502.
44. Li X, Song B, Xiang SH, Sodroski J (2007) Functional interplay between the Bbox 2 and the B30.2(SPRY) domains of Trim5alpha. Virology 366: 234-244.
45. Yamauchi K, Wada K, Tanji K, Tanaka M, Kamitani T (2008) Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. Febs J 275: 1540-1555.
46. Yang K, Shi HX, Liu XY, Shan YF, Wei B, et al. (2009) TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 182: 3782-3792.
47. Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR (1989) An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339: 389-392.
48. Ylinen LM, Keckesova Z, Wilson SJ, Ranasinghe S, Towers GJ (2005) Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by Trim5alpha alleles. J Virol 79: 11580-11587.
49. Pacheco B, Finzi A, Stremlau M, Sodroski J (2010) Adaptation of HIV-1 to cells expressing rhesus monkey Trim5alpha. Virology 408: 204-212.
50. Dittmar MT, Zekeng L, Kaptue L, Eberle J, Krausslich HG, et al. (1999) Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon. AIDS Res Hum Retroviruses 15: 707-712.
51. Rajsbaum R, Stoye JP, O'Garra A (2008) Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur J Immunol 38: 619-630.